Curative treatment of colorectal peritoneal carcinomatosis: Current status and future trends

European Journal of Surgical Oncology

Volumn 36, Issue 7, 2010, Pages 599-603

  Maggiori, L ^a   Elias, D ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CARCINOMATOUS PERITONITIS; CYTOREDUCTIVE SURGERY; FEASIBILITY STUDY; GOLD STANDARD; HIGH RISK PATIENT; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; MORBIDITY; MORTALITY; PERITONEUM CANCER; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; REVIEW; SURVIVAL RATE; TREATMENT INDICATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77953913957     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.05.007     Document Type: Review

References (25)

1. Chu D.Z., Lang N.P., Thompson C., et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 63 (1989) 364-367
2. Sadeghi B., Arvieux C., Glehen O., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88 (2000) 358-363
3. Jayne D.G., Fook S., Loi C., et al. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89 (2002) 1545-1550
4. Spratt J.S., Adcock R.A., Muskovin M., et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 40 (1980) 256-260
5. Sugarbaker P.H., Cunliffe W.J., Beliveau J.F., et al. Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treatment 1 (1988) 66-79
6. Los G., Mutsaers P.H., van der Vijgh W.J., et al. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res 49 (1989) 3380-3384
7. van de Vaart P.J., van der Vange N., Zoetmulder F.A., et al. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer 34 (1998) 148-154
8. Koga S., Hamazoe R., Maeta M., et al. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res 44 (1984) 1840-1842
9. Elias D., Detroz B., Debaene B., et al. Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts. Hepatogastroenterology 41 (1994) 207-213
10. Zoetmulder F.A. Cancer cell seeding during abdominal surgery: experimental studies. Cancer Treat Res 82 (1996) 155-161
11. Jacquet P., Elias D., and Sugarbaker P.H. [Tumor implantation in cicatrization sites following surgery for digestive cancers]. J Chir (Paris) 133 (1996) 175-182
12. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 3737-3743
13. Elias D., Lefevre J.H., Chevalier J., et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27 (2009) 681-685
14. Elias D., Gilly F., Boutitie F., et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol (2010 January)
15. Elias D., Benizri E., Pocard M., et al. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 32 (2006) 632-636
16. Verwaal V.J., van Ruth S., Witkamp A., et al. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 12 (2005) 65-71
17. da Silva R.G., and Sugarbaker P.H. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 203 (2006) 878-886
18. Elias D., Raynard B., Farkhondeh F., et al. Peritoneal carcinomatosis of colorectal origin. Gastroenterol Clin Biol 30 (2006) 1200-1204
19. Elias D.M. Peritoneal carcinomatosis or liver metastases from colorectal cancer: similar standards for a curative surgery?. Ann Surg Oncol 11 (2004) 122-123
20. Chua T.C., Saxena A., Schellekens J.F., et al. Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment. Ann Surg 251 (2010) 101-106
21. Sugarbaker P.H. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14 (1998) 254-261
22. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 221 (1995) 29-42
23. Elias D, Sideris L, Baton O, Lasser P, Pocard M. Traitement chirurgical á; viseće curatrice des carcinoses pećritonećales. In: EMC Techniques chirurgicales - Appareil Digestif 40-085; 2004.
24. Bonastre J., De Baere T., Elias D., et al. Cost of radiofrequency ablation in the treatment of hepatic malignancies. Gastroenterol Clin Biol 31 (2007) 828-835
25. Elias D., Goere D., Di Pietrantonio D., et al. Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 247 (2008) 445-450